Ronen M. Brenner

62 HaLohamim St
Holon, TA 58100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.

Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.

Journal: Medical sciences (Basel, Switzerland)

Published: June 26, 2026

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Journal: Frontiers in molecular biosciences

Published: May 11, 2026

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Journal: Medical sciences (Basel, Switzerland)

Published: April 24, 2026

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Journal: Medicina (Kaunas, Lithuania)

Published: March 30, 2026

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Journal: Medical sciences (Basel, Switzerland)

Published: March 09, 2026

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Journal: Frontiers in molecular biosciences

Published: March 03, 2026

Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell Carcinoma.

Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell Carcinoma.

Journal: Diagnostics (Basel, Switzerland)

Published: February 04, 2026

Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients.

Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients.

Journal: International journal of molecular sciences

Published: January 07, 2026

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

Journal: Diagnostics (Basel, Switzerland)

Published: October 20, 2025

Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm?

Worse prognosis of local and locally advanced head and neck Merkel cell carcinoma: Is it time to change the treatment paradigm?

Journal: Frontiers in immunology

Published: August 22, 2025

Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases.

Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases.

Journal: Medical sciences (Basel, Switzerland)

Published: August 17, 2025

Merkel cell carcinoma originating in the gluteal region.

Merkel cell carcinoma originating in the gluteal region.

Journal: JAAD case reports

Published: August 08, 2025

Showing 1-12 of 53

Last Updated: 09/26/2026